AtriCure (ATRC) Long-Term Investments (2011 - 2023)

AtriCure (ATRC) has 11 years of Long-Term Investments data on file, last reported at $7.6 million in Q2 2023.

• Long-Term Investments for Q2 2023 came in at $7.6 million, down 88.18% year-over-year; the trailing twelve-month figure through Jun 2023 was $7.6 million (down 88.18% YoY), and the FY2022 annual result was $51.5 million, down 50.63% from the prior year.
• Long-Term Investments retreated to $7.6 million in Q2 2023 per ATRC's latest filing, from $25.6 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $105.1 million in Q3 2021 and troughed at $7.6 million in Q2 2023.
• A 5-year average of $40.7 million and a median of $23.0 million in 2019 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments jumped 672.59% in 2022, then plunged 88.18% in 2023.
• A 5-year view of Long-Term Investments shows it stood at $12.7 million in 2019, then gained by 11.86% to $14.2 million in 2020, then jumped by 635.91% to $104.3 million in 2021, then tumbled by 50.63% to $51.5 million in 2022, then plunged by 85.25% to $7.6 million in 2023.
• Business Quant data shows ATRC's Long-Term Investments at $7.6 million in Q2 2023, $25.6 million in Q1 2023, and $51.5 million in Q4 2022.